To read this content please select one of the options below:

Organizational perspectives on implementing complex health interventions: clinical genomics in Australia

Stephanie Best (Australian Institute of Health Innovation, Macquarie University, North Ryde, Australia) (Australian Genomics, Murdoch Childrens Research Institute, Parkville, Australia)
Janet C. Long (Australian Institute of Health Innovation, Macquarie University, North Ryde, Australia)
Clara Gaff (Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) (The University of Melbourne, Melbourne, Australia)
Jeffrey Braithwaite (Australian Institute of Health Innovation, Macquarie University, North Ryde, Australia)
Natalie Taylor (Cancer Council New South Wales, Woolloomooloo, Australia) (The University of Sydney, Sydney, Australia)

Journal of Health Organization and Management

ISSN: 1477-7266

Article publication date: 22 July 2021

Issue publication date: 13 October 2021

235

Abstract

Purpose

Clinical genomics is a complex, innovative medical speciality requiring clinical and organizational engagement to fulfil the clinical reward promised to date. Focus thus far has been on gene discovery and clinicians’ perspectives. The purpose of this study was to use implementation science theory to identify organizational barriers and enablers to implementation of clinical genomics along an organizations’ implementation journey from Preadoption through to Adoption and Implementation.

Design/methodology/approach

We used a deductive qualitative approach study design drawing on implementation science theory - (1) Translation Science to Population Impact Framework, to inform semi structured interviews with organizational decision-makers collaborating with Australian and Melbourne Genomics, alongside and (2) Theoretical Domains Framework (TDF), to guide data analysis.

Findings

We identified evolving organizational barriers across the implementation journey from Preadoption to Implementation. Initially the organizational focus is on understanding the value of clinical genomics (TDF code: belief about consequences) and setting the scene (TDF code: goals) before organizational (TDF codes: knowledge and belief about consequences) and clinician (TDF codes: belief about capability and intentions) willingness to adopt is apparent. Once at the stage of Implementation, leadership and clarity in organizational priorities (TDF codes: intentions, professional identity and emotion) that include clinical genomics are essential prerequisites to implementing clinical genomics in practice. Intuitive enablers were identified (e.g. ‘providing multiple opportunities for people to come on board) and mapped hypothetically to barriers.

Originality/value

Attention to date has centred on the barriers facing clinicians when introducing clinical genomics into practice. This paper uses a combination of implementation science theories to begin to unravel the organizational perspectives of implementing this complex health intervention.

Keywords

Acknowledgements

This study was funded through Australian Genomics Health Alliance via the NHMRC Targeted Call for Research grant (GNT1113531): “Preparing Australia for Genomic Medicine”.

Citation

Best, S., Long, J.C., Gaff, C., Braithwaite, J. and Taylor, N. (2021), "Organizational perspectives on implementing complex health interventions: clinical genomics in Australia", Journal of Health Organization and Management, Vol. 35 No. 7, pp. 825-845. https://doi.org/10.1108/JHOM-12-2020-0495

Publisher

:

Emerald Publishing Limited

Copyright © 2021, Emerald Publishing Limited

Related articles